跳至主要内容
临床试验/CTRI/2022/05/042936
CTRI/2022/05/042936招募中未知

Multiomics approach to identify early detection biomarkers - A multi cancereffort in India

Strand Life Sciences Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Patients with confirmed malignant and benign neoplasms who are eligible for surgical resection, chemotherapy or radiation treatments, as identified by the site Principal Investigator or Co-Investigators through routine clinical care processes.
  • 2. Age- 18 years and above.
  • 3. Patients must have normal laboratory criteria as defined below:
  • â?? Platelets >100,000/mcL
  • â?? PTT as per institutional limits
  • â?? INR as per institutional limits
  • 4. Patients who have not undergone any oncosurgery.
  • 5. Patients who are treatment-naïve.
  • 6. Both men and women of all races and ethnic groups are eligible for this study.
  • 7. Ability to understand and the willingness to sign a written Informed Consent Form.

排除标准

  • 1. Subjects who have undergone prior chemotherapy, targeted therapy or radiation therapy
  • 2. Subjects with recurrent or relapse cases
  • 3. Patients who have an uncontrolled infection
  • 4. Patients who are receiving any oncology investigational agent(s)
  • 5. Patients who are coagulopathic and are taking blood thinning products
  • 6. Women who are pregnant or suspect they are pregnant and lactating mothers

研究者

相似试验